Small Molecules
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
494
NCT03482648
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 20, 2018
Completion: Oct 3, 2018
NCT03830125
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Start: Feb 13, 2019
Completion: Nov 24, 2019
NCT03800420
Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Phase: Phase 2
Start: Apr 22, 2019
Completion: Jul 31, 2020
NCT04138836
Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects
Start: Sep 17, 2019
Completion: Nov 4, 2019
NCT04138849
Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male
Start: Oct 1, 2019
Completion: Oct 25, 2019
NCT04820023
Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment
Phase: Phase 1/2
Start: Apr 2, 2021
Completion: Nov 29, 2023
NCT04478825
Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Start: Jun 1, 2021
Completion: Aug 24, 2021
NCT04596293
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Start: Jun 11, 2021
Completion: Jul 12, 2022
NCT05483907
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
Start: Apr 12, 2023
Completion: Feb 23, 2025
NCT05920135
First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI
Start: Sep 11, 2023
Completion: Aug 1, 2028
Loading map...